Patent Number: 6,251,953

Title: Beta-carotene therapy of individuals having abnormal immunological and serological indices, and individuals having infections and diseases causing changes therein

Abstract: Methods for raising or maintaining the level of T4 cells in humans having a depressed T4 cell level and particularly in humans infected with HIV are provided. In these embodiments, T4 enhancing amounts of beta-carotene are administered. Methods are also provided for lowering or maintaining the levels of neopterin and/or .beta..sub.2 -microglobulin in humans having elevated levels of these indices and particularly in those infected with HIV. Beta-carotene is administered, respectively, in neopterin and .beta..sub.2 -microglobulin therapeutically effective amounts. Also contemplated by the present invention are methods for the prevention and/or treatment of HIV infection in humans. An HIV infection preventing or an anti-HIV therapeutically effective amount of beta-carotene is administered. In another embodiment, methods are provided for preventing or treating AIDS in humans. An AIDS preventing amount or an anti-AIDS therapeutically effective amount of beta-carotene is administered.

Inventors: Baranowitz; Steven (East Brunswick, NJ)

Assignee: Brookner; Andrew

International Classification: A61K 31/015 (20060101); A61K 31/01 (20060101); A01N 027/00 (); A61K 032/015 ()

Expiration Date: 06/26/2018